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ABSTRACT 
 
THE ASSOCIATION OF PRESCRIPTION OPIOID EXPOSURE AND  
PATIENT FACTORS WITH PROLONGED POSTOPERATIVE OPIOID USE IN 
OPIOID NAÏVE PATIENTS 
 
 
By 
Jennifer Lanzillotta 
August 2018 
 
Dissertation supervised by Melissa Kalarchian, PhD 
Background 
Research suggests prolonged postoperative opioid use occurs in 4-13% of opioid naïve 
patients and is related to factors other than surgical pain. However, it is unclear which 
patient factors and prescribing practices are associated with prolonged use after surgery 
among opioid naïve patients.  
Objectives 
To identify factors associated with prolonged postoperative opioid use (refills 90-180 
days after surgery) in opioid naïve patients in two domains: specific patient 
characteristics (demographics, smoking status, comorbidities, etc.) and exposure through 
postoperative opioid prescriptions (in oral morphine milligram equivalents [OME]).  
 
  v 
Methods 
An electronic medical record dataset analysis of inpatient and outpatient opioid naïve 
adult orthopedic surgery patients at the University of Cincinnati Medical Center from 
January 1, 2012 through December 31, 2017 was conducted. Opioid naïve was defined as 
no opioid prescription filled in the past twelve months or only a perioperative 
prescription filled 30 days or less prior to surgery. Patients were excluded if they had a 
diagnosis of cancer or if they underwent a second surgery within 180 days of the first.  A 
multivariate logistic regression model was used to evaluate the relationship of each 
domain to opioid refills 90-180 days after surgery.  
Results 
Of the 7,323 patients met inclusion criteria, 4% continued to refill opioid prescriptions 
more than 90 days after their surgical procedure. Independent predictors of prolonged 
postoperative opioid use were alcoholism (O.R. 2.0, C.I. 1.5-2.6), OME > 675 (O.R. 2.3, 
C.I. 1.5-3.4), female gender (O.R. 1.7, C.I. 1.3-2.1), black race (O.R. 1.6, C.I. 1.2-2.2), 
Medicaid insurance (O.R. 1.8, C.I. 1.3-2.5), and the following co-morbidities: diabetes 
(O.R.1.5, C.I. 1.1-2.0), mood disorders (O.R. 1.4, C.I. 1.1-1.9), hypertension (O.R. 1.4, 
C.I. 1.1-1.9), and chronic kidney disease (O.R. 1.6, C.I. 1.1-2.4). 
Conclusions 
 Both opioid exposure and patient characteristics increase risk for prolonged opioid use 
following orthopedic surgery. Since the risk of overdose increases with increased OME, 
patients with high OME prescriptions should also receive a prescription for naloxone. 
This study sheds light on the need for postoperative prescribing guidelines for clinicians. 
To decrease the rate of prolonged postoperative opioid use, clinical changes can be 
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investigated and implemented including collaborative perioperative pain management 
strategies utilizing non-opioid pain control methods; perioperative patient screening; 
education of patients and clinicians; and close postoperative follow-up, especially for the 
most vulnerable populations.  
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1.0 Dissertation Proposal 
THE TEMPORAL ASSOCIATION OF  
PATIENT CHARACTERISTICS AND PRESCRIBING PRACTICES  
WITH PROLONGED POSTOPERATIVE OPIOID USE  
 
1.1 Specific Aims 
The opioid crisis in the United States has reached epidemic proportions. Opioid overdose 
deaths nearly tripled in the fifteen years between 1999 and 2014 (Rudd, Aleshire, Zibbell, & 
Gladden, 2016). The rate of drug overdose deaths increased significantly in both males and 
females and among all adult age groups (Rudd, Akeshire, Zibbell, & Gladden, 2017). There were 
52,404 drug overdose deaths in 2015, up from 47,055 in 2014. Of these deaths, 63% (33,091) 
were attributed to opioids, the highest rate ever recorded. Ohio, the site of the proposed research, 
is ranked the fourth highest state in opioid overdose deaths (Rudd et al., 2017). 
There are many pathways to opioid misuse. Prescribing practices for managing post-
surgical pain are important in the development of opioid misuse and the conversion of acute pain 
to chronic pain (Kehlet, Jensen, & Woolf, 2006). Research suggests that prolonged postoperative 
opioid abuse is a common complication of elective surgery (Brummett et al., 2017). In fact, 
when opioid naïve patients (patients who have not taken an opioid for the past 12 months) are 
prescribed an opioid post-surgery, 6-13% are still taking the medication three months later 
(Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016a; Sun, Darnall, Baker, & 
Mackey, 2016). The overarching objective of this proposal is to identify risk factors for 
prolonged opioid use post-surgery, which will directly inform efforts to prevent opioid use 
disorder (OUD). 
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Surgery places patients at risk for long term opioid use through exposure to narcotics 
(Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016; Sun et al., 2016). However, 
research has been inconsistent as to which patient factors and prescribing practices are predictive 
of prolonged postoperative use (Carroll et al., 2012; Rozet et al., 2014; Sun et al., 2016). The 
proposed retrospective electronic medical record (EMR) chart review study of orthopedic 
surgery patients (n=422) aims to utilize the Availability-Proneness Theory of Illicit Drug Abuse 
framework to identify potential predictive factors of postoperative opioid use in the domains of 
exposure and patient factors (Smart, 1980). The data will be extracted from the EMR through an 
honest broker; data will be provided in a secure and HIPPA-compliant format.  
Specific Aims are as follows: 
Aim 1   
Determine if postoperative opioid exposure is related to prolonged postoperative opioid 
use. Exposure will be based on the initial post-surgery prescription as documented in the EMR, 
including the medication, milligrams per pill, number of days, and number of pills prescribed. 
Hypothesis 1.  Exposure (converted to morphine milligram equivalents [MME] per 
kilogram of body weight and length of prescription in days) will be associated with 
continued use (prescriptions refills at 30-, 60-, and 90-days post-surgery). 
Aim 2 
Determine if individual patient factors are related to prolonged postoperative opioid use. 
Patient factors will include demographics; smoking status; physical and psychological diagnoses 
via International Classification of Diseases, 9th Revision (ICD-10) codes; pre-surgery 
medications and history of opioid use; and the American Society of Anesthesiologists (ASA) 
physical status classification.   
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Hypothesis 2. Patient factors (e.g., history of opioid use, smoking status, psychological 
conditions, and increased number of comorbid conditions) will be associated with 
continued use (prescription refills at 30-, 60-, and 90-days post-surgery). 
Exploratory Aim 
Evaluate the relative contributions of exposure and patient factors in a multiple logistic 
regression model predicting opioid refills at 90-days. 
This study directly addresses National Institute of Drug Abuse (NIDA) funding priority 
areas: NIDA Goal #2 is to “develop new and improved strategies to prevent drug use and its 
consequences” (2016-2020 NIDA Stragetic Plan Advancing Addiction Science, 2016).  By 
“determining the mechanisms that underlie drug abuse and its consequences” this research 
meets NIDA objective 2.1. Findings will be used to develop screening tools to identify patients 
at high risk for opioid misuse, develop pain management protocols and prescribing guidelines, 
increase the use of multi-modal anesthetics targeting different pain pathways, increase regional 
anesthetic techniques, and develop educational strategies for patients, clinicians, and 
stakeholders, thus meeting other NIDA objectives. It will support the development of evidenced 
based best practices for pain management, and will help the nurse scientist applicant launch an 
independent program of funded research in this high priority area. 
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Background and Significance 
National Opioid Epidemic 
It is widely recognized that the United States is experiencing an opioid epidemic. There 
has been an urgent call to action at the national level by the U.S. Congress, the Centers for 
Disease Control and Prevention (CDC), the Department of Health and Human Services 
(Addressing Prescription Drug Abuse in the United States, 2013), the U.S. Department of Justice 
Drug Enforcement Agency (2016 National Drug Threat Assessment Summary, 2016), and the 
National Institutes of Health (2016-2020 NIDA Stragetic Plan Advancing Addiction Science, 
2016). Overdose deaths are increasing in males and females among all age groups; in 2015, 63%, 
or 33,091 overdose deaths, were attributed to opioids, the highest rate ever recorded (Rudd et al., 
2017). Ohio, the state where the proposed retrospective EMR chart review will be conducted, is 
ranked 4th in the nation in opioid overdose deaths (Rudd et al., 2017). There were 3,050 overdose 
deaths in Ohio in 2015, up from 2,531 in 2014, a 21% increase (2015 Ohio Drug Overdose Data: 
General Findings, 2015). Ohio ranked first in increased number of emergency department visits 
related to opioid misuse between 2009 and 2014 and there was a 52% increase in the number of 
inpatient admissions related to opioid misuse during that same time period (Weiss et al., 2017). 
In addition to the human toll, the economic burden of the opioid epidemic is staggering. 
The CDC’s estimated direct costs to insurers in 2011 for nonmedical use of prescription drugs 
was over $72 billion per year ("Prescription Painkiller Overdoses in the U.S.," 2011).  Although 
men continue to misuse opioids more than women, this gap is narrowing ("Prescription 
Painkiller Overdoses," 2013). The CDC reported a 400% increase in the use among women since 
1999 compared to a 265% increase among men; the female age groups most affected are women 
  5 
of childbearing age ("Prescription Painkiller Overdoses," 2013). Thus, a better understanding of 
risk factors could have a major public health impact. 
Postsurgical Pain Management Contributes to the Opioid Epidemic 
Prescription opioid abuse is contributing to the heroin epidemic: people often turn to 
heroin when they are unable to obtain pain pills (Compton, Jones, & Baldwin, 2016). In fact, the 
strongest predictor of heroin use disorder is previous prescription opioid dependence or opioid 
use disorder; those who misuse opioids are 40 times more likely to become dependent on heroin 
("New research reveals the trends and risk factors behind America’s growing heroin epidemic," 
2016).  
Prescribing practices are an important component in preventing drug substance use 
disorder ("New research reveals the trends and risk factors behind America’s growing heroin 
epidemic," 2016). In fact, a surgical procedure was the precipitating pain event in 10-50% of 
chronic pain patients depending upon the procedure (Kehlet et al., 2006). Brummet et al. (2017) 
found that 6% of patients continued to fill opioid prescriptions whether the surgery was major or 
minor, suggesting factors other than chronic pain contribute to long term use; Johnson et al. 
(2016) found 13% of patients continue to fill opioid prescriptions more than 3 months after 
surgery. Eliminating opioids entirely is not feasible, as this would prevent patients in severe pain 
from obtaining relief. Therefore, clinicians need to strategically manage acute surgical pain in 
order to minimize long-term opioid misuse and abuse.  
Post-surgery Prescribing Practices may Place Patients at Risk for Prolonged Opioid Use 
Surgical exposure to opioids places patients at risk for prolonged use. Previous literature 
has commonly operationalized ninety days as significant long-term opioid use post-surgery, 
referred to in this application as “prolonged use” (Manchikanti et al., 2012).  Three studies 
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showed that a surgical procedure places opioid naïve patients at risk for chronic opioid use. 
Johnson et al. (2016) found that 13% of opioid naïve patients continued to fill prescriptions 90 
days post-surgery. Carroll et al. (2012) found that 5% of opioid naïve patients continued to use 
opioids greater than 150 days after a surgical procedure. Sun et al. (2016) found that seven of the 
eleven surgical procedures examined placed opioid naïve patients at increased risk for chronic 
opioid use. 
Studies indicate that opioids are overprescribed after surgery and that there is wide 
variation in prescribing practice. Recent studies indicate opioids are overprescribed after surgery. 
In a survey of patients, less than 40% of urology patients used all of their opioid pain medication 
after surgery; only 58% of the prescribed medication was used (Bates, Laciak, Southwick, & 
Bishoff, 2011). In another survey of patients, less than one third of the prescribed opioid pain 
medication was used by patients after their elective upper extremity surgical procedure (Rodgers, 
Cunningham, Fitzgerald, & Finnerty, 2012). A prospective observational study examined 
patients undergoing dermatology surgery. Only 11% of the patients used all of the prescribed 
opioids (Harris et al., 2013). Overall, less than 40% of the prescribed pain medication was used. 
The authors also reported wide variation in opioid prescribing practices among the physicians in 
this study. In a retrospective chart review, wide variation in prescriber practices occurred not 
only nationally, but within the same healthcare facility (Harris et al., 2014).  These findings 
indicate inconsistency in postoperative pain management practices, overprescribing of opioids, 
and prolonged use after surgery that may be related to factors other than pain.    
Individual Patient Characteristics Also Confer Risk  
Certain patient characteristics may be predictive of postoperative opioid use, but these are 
inconsistently reported across studies. Demographics such as gender, age, and socioeconomics 
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were particularly inconsistent. For instance, in one large analysis, the patient demographics 
predicting prolonged postoperative opioid use were age less than 65, female gender, household 
income under $60,000 per year, and private insurance (Johnson et al., 2016). Conversely, in 
another large database analysis, men and patients over 50 years of age had higher rates of 
prolonged use (Sun et al., 2016). Another study found no difference in opioid use six months 
after surgery by age, gender, ethnicity, or type of surgery (Goesling et al., 2016). Rates also 
varied by geographic location. Statistically significant higher rates of prolonged opioid use were 
found in the U.S. Census Bureau West South Central (7.02%) and East South Central (7.85%) 
regions compared to the Middle Atlantic Region (3.78%) (Brummett et al., 2017). 
Researchers consistently found that patients who are already on opioids, 
benzodiazepines, or addicted to alcohol are at increased risk of prolonged postoperative use 
(Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al., 2014; Sun 
et al., 2016; Waljee et al., 2016). In fact, mental health disorders, tobacco and alcohol abuse, 
multiple comorbid conditions, and pre-existing pain conditions were independent predictors of 
prolonged postoperative opioid use across all surgical procedures (Brummett et al., 2017; 
Johnson et al., 2016). Preoperative opioid prescriptions, depressive symptoms, and self-
perceived risk of addiction predicted prolonged postoperative use more than postoperative 
intensity and duration of pain (Carroll et al., 2012). One study found that a preoperative 
opioid prescription greater than 60 morphine milligram equivalents per day was associated with 
prolonged use after surgery (Goesling et al., 2016). Additionally, patients already on opioids 
preoperatively were often overprescribed opioids postoperatively (Waljee et al., 2016). Lastly, 
post-traumatic stress disorder (PTSD) and preoperative opioid use were factors leading to 
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chronic postoperative opioid use in young veterans having minor elective surgeries (Rozet et al., 
2014). 
In summary, current evidence suggests that prolonged postoperative opioid use is related 
to factors other than the duration and severity of surgical pain. Patients already using opioids, 
benzodiazepines, tobacco, or abusing alcohol were at higher risk for prolonged postoperative 
opioid use (Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al., 
2014; Sun et al., 2016; Waljee et al., 2016). Mental health disorders such as anxiety and 
depression, a self-perceived risk of addiction, and multiple comorbid conditions independently 
predicted prolonged use (Brummett et al., 2017; Carroll et al., 2012; Johnson et al., 2016). The 
contribution of patient demographics is conflicting across studies.  
 The American Society of Anesthesiologists (ASA) physical status classification system was 
developed to provide a uniform method for statistical analysis, for communication among 
colleagues, and for other record keeping purposes. This system classifies patients according to 
disease morbidity. (Johnson et al., 2016). The system, universally utilized by all anesthesia 
providers for each surgical procedure, could ultimately assist providers in selecting multi-modal 
pain management strategies for high risk populations and help guide postoperative acute pain 
control methods. This system is summarized in Appendix 1. 
 ASA status was reported in two studies: a retrospective chart review of knee arthroscopies in 
veterans and a prospective cohort study on the effect of preoperative opioid use in spine 
surgeries (Armaghani et al., 2014; Rozet et al., 2014). Although neither of the two studies 
indicated a statistically significant difference in postoperative opioid use related to ASA status, 
certain studies have shown an increase related to increasing comorbidities. 
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Proposed Retrospective EMR Chart Review Study 
These early studies have begun to lay a foundation of knowledge for future research, but 
significant gaps remain. The literature does not consistently identify which patients are at risk for 
prolonged postoperative opioid use, or how prescribing practices influence prolonged 
postoperative opioid use (Clarke, Soneji, Ko, Yun, & Wijeysundera, 2014). Examining opioid 
use 30 days after surgery is also important because this indicates a high probability of continued 
long term use at 90 days (Shah, Hayes, & Marting, 2017). Determining how (1) postoperative 
opioid exposure (measured in morphine milligram equivalents [MME] per kilogram of body 
weight and length of prescription in days) is related to prolonged postoperative opioid use at 30, 
60, and 90 days and (2) determining individual patient factors related to prolonged opioid use, 
including preoperative drug use, the patient’s physical and psychological medical conditions, 
ASA status, and demographics, will address the gap in knowledge. The MME conversion table 
is presented in Appendix 2.  
The proposed retrospective EMR chart review study will extend previous work in several 
ways. Current research has mainly focused on patients over age 64 with private insurance 
(Johnson et al., 2016; Rozet et al., 2014; Sun et al., 2016; Waljee et al., 2016). This research will 
not exclude adult patients based on age nor type of insurance or lack thereof. Both exposure and 
patient factors will be examined in tandem. By evaluating the relative contributions of exposure 
and patient factors, it is anticipated that we can account for some of the variability in prolonged 
use. Previous literature has commonly described ninety days as significant prolonged use post-
surgery (Manchikanti et al., 2012).  Recent findings indicate that the risk of prolonged opioid use 
increases after the first five days of therapy and again after 30 days of therapy regardless of the 
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reason for the prescription (Shah, Hayes, & Martin, 2017). Because of this evidence, opioid use 
at 30, 60, and 90 days postoperatively will be analyzed. 
Surgery places patients at risk for prolonged opioid use, but the contributions of 
prescribing practices and patient risk factors is unclear. Findings from the proposed study will be 
used to develop evidenced based best practices for pain management, including screening tools, 
perioperative pain management protocols and prescribing guidelines, increased use of multi-
modal anesthetics targeting different pain pathways and regional anesthetic techniques, and 
educational strategies for patients, clinicians, and stakeholders.  
Theoretical Framework for the Proposed Dissertation Study   
The design of this dissertation research is based on The Availability-Proneness Theory of 
Illicit Drug Abuse (Smart, 1980). This theory can be tested empirically; support for this theory 
can be found in recent literature examining factors contributing to drug abuse (Ayllón & 
Ferreira-Batista, 2017; Barrett, Joe, & Simpson, 1990; Rigg & DeCamp, 2014; Rigg & Murphy, 
2013; Zeinali & Vahdat, 2011). This theory remains timely: it is currently utilized to explain 
opioid dependence following exposure via prescriptions and was used to develop the Addiction 
Susceptibility Questionnaire to measure a person’s likely predilection to drug abuse (Rigg & 
DeCamp, 2014; Rigg & Murphy, 2013; Zeinali & Vahdat, 2011).  
Basic tenets of this theoretical framework include that drug abuse occurs when two 
factors are met: (1) the ease of access to drugs for an individual (exposure) and (2) the individual 
patient factors contributing to the likelihood of abuse (proneness) (Smart, 1980). Thus, the theory 
can be used to explain OUD in different populations, whether inner city, medical professionals 
with high access to opioids, or post-surgical patient populations. Proneness to drug abuse is a 
psychological construct. It describes a person’s innate tendency to seek out and use drugs. Those 
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with low proneness will not seek out drugs, but may become dependent if there is a high 
availability, such as a postoperative prescription or if they live in an environment where illicit 
drugs are commonly available. Persons with certain predictive characteristics--proneness--will 
seek drugs out, even when availability is low.  
Persons who otherwise would not experience opioid exposure do so postoperatively. 
Thus, this theory can be used to explain why some studies indicate a greater proportion of our 
opioid-naïve patients who convert to opioid misuse after surgery (exposure) do not fit our 
paradigm of drug abusers:  they are young, female, and covered by private insurance (Johnson et 
al., 2016). It also may explain why the gap between males and females is closing, and why 
females of child-bearing age are greatly affected (Addressing Prescription Drug Abuse in the 
United States, 2013). The second prong of this theory associates individual patient factors with 
risk of SUD.  If we identify predictors of abuse, we can identify high risk patients and intervene 
more readily to prevent subsequent SUD.  
This dissertation research seeks to identify potential predictive factors of postoperative 
opioid use in these two domains through a retrospective EMR chart review.  The theoretical 
framework as it applies to this research proposal is shown in Figure 1. Proneness is represented 
by patient factors (Table 1). We will examine patients undergoing orthopedic surgery and their 
subsequent initial exposure to opioids. According to our hypotheses, patient factors and initial 
exposure will be associated with subsequent prescription refills. We will measure prescription 
refills at 30, 60, and 90 days as described to determine prolonged use, which could lead to OUD. 
 
  
1
2
 
Theoretical Framework (Adapted from The Availability Proneness Theory of Illicit Drug Abuse Model by Smart, 1980.)
PRONENESS:  
Patient Factors:  
Hx of opioid 
use/preoperative 
exposure to opioids 
Smoking 
Demographics 
ASA Status 
Psychological 
conditions 
Physical comorbidites 
SUBSTANCE USE DISORDER 
Mild         Moderate           Severe 
 
 
Orthopedic 
surgery 
EXPOSURE
: 
Perioperative 
Opioid 
Prescription 
(MME) 
Opioid 
Prescription 
Refills 
(30, 60, 90 days 
post-surgery) 
Prolonged 
post-
operative 
opioid use 
More than 90 
days post-
surgery 
Opioid Use 
Disorder 
(Addiction) 
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Pathophysiology of Drug Abuse 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) describes SUD with 
four major categories: impaired control, social impairment, risky use, and pharmacological 
criteria such as tolerance and withdrawal. It can be classified as mild, moderate, or severe. Not 
all persons exposed to opioids will progress down the SUD continuum. The most severe form of 
SUD is estimated to affect 10% of the population (Volkow, Koob, & McLellan, 2016). Although 
addiction is not defined by the American Psychiatric Association, the term is still commonly 
used and represents the end of the SUD continuum; addiction can be considered the severe form 
of SUD (Volkow et al., 2016).  
The disease model of addiction describes OUD similarly to other chronic health 
conditions such as diabetes and heart disease: it the result of a combination of genetic, 
behavioral, environmental, and biological factors. Changes in brain neurobiology in response to 
drug use include up and down regulation of neuronal receptors and neurotransmitter changes. 
This results in impaired dopamine release, conditioned responses, and re-setting of the brain-
reward system, thus altering motivation and behavior (Volkow et al., 2016). Once the person has 
progressed to severe SUD, craving overrides behavioral control despite negative consequences. 
The disease is characterized by relapse and can be progressive, leading to disability and 
premature death. This definition is accepted by the American Medical Association and the 
American Society of Addiction Medicine (ASAM) ("Definition of Addiction," 2017).  
Fit with National Priorities 
The National Institute on Drug Abuse (NIDA), in response to this epidemic, released its 
strategic plan for 2016-2020 with goals and objectives to stem the tide. Goal #2 is to “Develop 
new and improved strategies to prevent drug abuse and its consequences.” One objective of the 
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goal is to determine the mechanisms that underlie individual risk and resilience for addiction and 
common comorbidities, which is a fit with the proposed retrospective EMR chart review 
dissertation study by a nurse scientist (2016 National Drug Threat Assessment Summary, 2016). 
Innovation 
This innovative dissertation research will provide new insight into developing strategies 
to combat the national opioid epidemic by using a theoretically grounded approach to studying 
the effect of prescribing practice (exposure) and the predictors of SUD (proneness) together.  
The innovation of this research lies in the ability to examine both prescribing practices and 
patient characteristics for comparison and analysis of their relative contributions to prolonged 
opioid use.  
As mentioned earlier, previous studies have not examined the impact of prescribing 
practices in conjunction with predictors of prolonged postoperative opioid use (Clarke et al., 
2014).  For example, Johnson et al. (2016) examined the predictors of prolonged opioid use in 
opioid naïve patients after common hand surgeries, but did not examine the medications 
prescribed, medication dosages, or number of pills dispensed. Sun et al. (2016) concluded that 
opioid naïve patients are put at risk for long-term opioid use after surgery, but the research did 
not examine the provider prescribing practices that may have influenced the outcomes. In a 
review by Manchikanti and colleagues (2012), the authors conclude that the greatest contributors 
to the current opioid epidemic are prescribing patterns based on misinformation, lack of 
education, the perceived safety of opioids, lack of willingness of patients to use other pain 
control modalities, and health system barriers. Thus, research to date has tended to focus on 
either prescribing or exposure, but has not considered both together. 
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In short, this project will move science forward by examining the post-surgical provider 
prescribing practices (exposure) and the predictors of prolonged use (proneness) in tandem.  This 
will, in turn, lead to identification of patients at high risk for postoperative opioid misuse, 
development of pain management protocols and prescribing guidelines, increase in the use of 
multi-modal anesthetics targeting different pain pathways, and the development of educational 
strategies for patients, clinicians, and stakeholders, ultimately decreasing postoperative opioid 
misuse, a national crisis.  
Research Design and Methods 
Overview and Research Design 
We propose a retrospective EMR chart review to (1) examine the temporal association of 
postoperative opioid exposure (measured in MME per kilogram of body weight and length of 
prescription in days) to prolonged opioid use at 30, 60, and 90 days post-surgery and (2) 
determine individual patient factors related to prolonged opioid use, including history of opioid 
use, demographics, smoking status, and certain physical and psychological conditions. 
Setting   
  The EMR chart review will be conducted at University of Cincinnati Medical Center 
(UCMC), a large, urban teaching hospital that is part of an academic medical center. This site 
treats Medicare, Medicaid, private insurance, self-pay, and the uninsured. The data will be 
extracted by Biomedical Informatics, the institutional Honest Broker for UC Health. The data 
will be provided in a secure, HIPPA-compliant format ensuring patient confidentiality and 
protection will be maintained. There are five Epic-trained database analysts on the team and 
supporting faculty with broad informatics experience that will lend their expertise during this 
retrospective EMR chart review.  Biomedical Informatics has provided a letter of support 
  16 
confirming that they will provide the required data in a compliant and secure format along with 
supporting personnel.  The UCMC Chief Nursing Officer and Vice President of Patient Care 
Services has also provided a letter of support confirming access to the Epic EMR for this 
research study.  
Sample 
The sample for this research will consist of orthopedic surgery patients who underwent 
surgery at UCMC. This class of surgery was selected because research of privately insured, 18 to 
64-year-old patients, showed orthopedic surgeries to be the highest risk for prolonged 
postoperative opioid use and that preoperative opioid use is highest in orthopedic patients (Sun et 
al., 2016; Wilson et al., 2015). Inclusion criteria are (1) over age 18, (2) having had orthopedic 
surgery, and (3) received a perioperative opioid prescription in the time frame of 30 days prior to 
surgery through postoperative discharge. The exclusion criterion is patients without a current or 
previous diagnosis of cancer according to the ICD medical codes because cancer pain treatment 
is vastly different from acute pain treatment.  Both opioid naïve patients and patients using 
opioids preoperatively will be included. For this research, opioid naïve is defined as patients who 
have not filled an opioid prescription in the past twelve months or who only filled a perioperative 
prescription; perioperative prescriptions are defined as thirty days or less prior to surgery so that 
patients have their pain medication available at home immediately following discharge.  
Data Collection 
Data will be extracted from the Epic EMR by an honest broker. Prescriptions for opioids 
will be extracted from the EMR. Data collected will include the medication prescribed; the 
number of pills and days prescribed; and the milligrams per pill. MME dosages will be 
calculated for comparison among different opioids. This method is often used in the literature for 
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comparison among opioids and is also used by clinicians. The patient’s body mass index (BMI) 
(kg/m2) will be calculated based on height and weight as documented in the medical record.  
Table 1 summarizes the data to be extracted from the EMR.  
Table 1 
Data to be Collected and Coded from the Electronic Medical Record 
 Variable Data to be extracted Coding 
Patient Factors Demographics Age Months, years 
Gender  Male (yes/no) 
Race 
 
White or Caucasian  
Black or African American 
Asian 
American Indian and Alaskan Native 
Ethnicity Hispanic (yes/no) 
 
Weight status Height and Weight BMI (Kg/m2)  
 
Smoking status Smoker Yes/no 
 
Physical status ASA Category Status (I, II, III, IV, E) 
Type of insurance Insurance at time of 
surgery 
Private Insurance 
Medicaid 
Medicare 
No insurance or self-pay 
 
Medical Conditions ICD Codes  Diabetes 
Chronic obstructive pulmonary disease 
Emphysema 
Coronary artery disease 
Hypertension 
Obesity 
Mood disorders 
Chronic pain 
Cerebrovascular disease 
Chronic Kidney disease 
Liver disease 
Alcoholism 
Drug abuse 
 
Preoperative 
Prescriptions  
Type of medication Antidepressants 
Antipsychotics 
Antianxiety 
Opioid *  
Non-opioid pain medication 
Other 
 
Person undergoes 
surgery 
Type of Surgery 
 
Specific orthopedic 
procedure 
 
Total knee arthroplasty 
Total hip arthroplasty  
Spine surgery 
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Shoulder surgery 
Upper extremity surgery (non-joint 
replacement) 
Lower extremity surgery (non-joint 
replacement) 
Other 
 
Trauma Yes/No 
 
Exposure Perioperative & 
Postoperative Opioid 
Prescriptions 
Number of pills, 
number of days, mg per 
pill 
Morphine milligram equivalents (if 
applicable)  
 Date of prescription > 30 days pre-surgery 
< 30 days pre-surgery 
At time of surgery * 
30-59 days post-surgery 
60-89 days post-surgery 
90-180 days post-surgery * 
 
Refill Yes/no * 
 
* Primary outcome = Prolonged opioid use defined as opioid prescription refills 90-180 days 
post-surgery (categorical) 
 
Power and Sample Size  
 Based on power of .80, .05 for alpha, an odds ratio of 1.5, with the proportion of people 
at 13% (Pr(Y=1|X=1) and a two-tailed test, a sample size of 422 is needed (Faul, Erdfelder, 
Buchner, & Lang, 2009; Johnson et al., 2016). Due to the change in opioid prescribing practices 
over time, orthopedic surgery patients from 2012 forward will be considered (Wunsch, 
Wijeysundera, Passarella, & Neuman, 2016). As the cost of analyzing more EMRs does not 
increase with a greater sample size, we will collect data on the maximal number of patients 
available in the specified time period.  
Data Analysis  
Data analysis will be completed by the PhD student PI working with a data analyst under the 
supervision of a statistician. Following data extraction by an honest broker from the EMR, a 
research assistant will help with data cleaning and creation of a data dictionary. Completeness of 
records will not be known until data pulled and will be addressed with statistician. We will begin 
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by examining the primary outcome variable to see how many patients have refilled a prescription 
at 90 days (primary outcome; binary). We will also calculate variables such as MME. 
Descriptive analyses will be run for means and standard deviations for continuous predictor 
variables, and frequency and ranges of scores will be examined for categorical variables, to 
identify any outliers. For continuous variables that are non-normally distributed (e.g. number of 
days from the initial opioid prescription), we will examine the distribution to create categories 
(e.g. more or less than one week). Any three-category variables will be dummy coded in 
preparation for modelling. Reference groups will be labelled as zero. 
Following the descriptive analysis and recoding, Chi-squared analysis will be run based 
on use at 90-days post-surgery and each categorical variable individually. We will run cross-tabs 
to make sure we have sufficient number of observations at each crosstab (5 or more in each cell).  
All variables that are statistically significantly related to the 90-day outcome will be considered 
for the modelling. Before beginning the modeling, tests for multicollinearity, influential cases, 
and linearity of logit will be conducted to verify that all assumptions of the logistical regression 
model are met.  
A logistic regression model will be used to evaluate study hypotheses and identify factors 
that predict prolonged opioid use. The categorical variable of refill at 90 days will be entered as 
the dependent outcome variable, and the variables that were identified from the individual Chi 
square analyses as the independent predictor variables. The Wald statistic will be used to 
determine the contribution of each predictor to the model. The beta weight will be used to 
evaluate the strength and direction of the association. Cox and Snell pseudo R squared will be 
used to determine the explanatory power of the model in relation to the variance in the dependent 
variable that is due to the independent variable. The odds ratio for each of the predictors will 
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allow us to determine how many times that predictor increases the odds of refilling a prescription 
at 90 days. A p-value < .05 will be used as the criterion for determining significance.  
Study Hypotheses will be Evaluated as Follows  
Hypothesis 1.  Exposure (converted to morphine milligram equivalents [MME] per 
kilogram of body weight and length of prescription in days) will be significantly associated with 
continued use (prescriptions refills at 30-, 60-, and 90-days post-surgery). The predictor variable 
will be MME and the outcome variable will be refills at 90 days.  
Hypothesis 2. Patient factors (e.g., history of opioid use, smoking status, psychological 
conditions, and increased number of comorbid conditions) will be significantly associated with 
continued use (prescription refills at 30-, 60-, and 90-days). A hierarchical variable model where 
the variables observed to be related to the outcome will be entered based on their theoretical 
importance (forward entry). In addition, Chi-square change in fit of each successive model will 
be examined to determine significance of the added predictor variable.  
Exploratory aim.  We will evaluate the relative contributions of exposure and patient 
factors in a multiple logistic regression model predicting opioid use at 90-days. A logistic 
regression analysis will be run with prolonged opioid use as the dependent variable and the 
variables that were retained in the evaluation of hypotheses 1 and 2 as the independent variables, 
using an approach similar to that outlined above to explore the relative contributions of exposure 
and patient characteristics. 
Limitations 
This dissertation study has several limitations: (1) this research will examine orthopedic 
patients so the results may not be generalizable to all surgery patients, (2) this study may not 
reflect the population of the nation as a whole, and (3) patients may seek opioids from outside 
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sources that will not be captured in the EMR. It is also possible that there will not be sufficient 
variability in prescribing practices or the outcome variable to conduct the modeling and detect 
the anticipated effects, and if we encounter this pitfall, the descriptive findings will inform and 
guide future work. 
Future Directions 
 The proposed study is the first step in a research career in a high priority area. Results will 
be published in peer-reviewed journals, presented at interprofessional conferences, and used to 
support future grant applications. Ultimately, this body of research will lead to the development 
of pain management protocols and postoperative prescribing guidelines, increased use of multi-
modal anesthetics targeting different pain pathways, increased regional anesthetic techniques, 
and the development educational strategies for patients, clinicians, and stakeholders. 
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Appendix A 
American Society of Anesthesiologist Physical Status Classification 
Status Definition Examples (not an exhaustive list) 
ASA I 
 
Normal, healthy patient  
ASA II A patient with mild systemic 
disease 
Smoker, mild alcohol use, pregnancy, 30< BMI<40, well 
controlled diabetes and high blood pressure, mild lung 
disease 
 
ASA III A patient with severe systemic 
disease 
Poorly controlled diabetes or high blood pressure, morbid 
obesity (BMI >40), alcohol dependence, history of stroke, 
myocardial infarction, coronary artery disease, pacemaker, 
dialysis 
 
ASA IV A patient with severe systemic 
disease that is a constant threat to 
life 
Symptomatic lung disease, symptomatic heart disease, 
hepatorenal failure.  Has at least one disease that is poorly 
controlled (hypertension, diabetes) 
 
ASA V 
 
 
Patients not expected to survive 
more than 24 hours without 
surgery 
 
Multi-organ system failure 
ASA VI 
 
A declared brain-dead patient Organ procurement 
From American Society of Anesthesiologists https://www.asahq.org/resources/clinical-
information/asa-physical-status-classification-system. Retrieved May 2017.  
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Appendix B 
Morphine Milligram Equivalent Conversion Table 
Opioid (doses in mg/day except where noted) Conversion Factor 
Codeine 0.15 
Fentanyl transdermal (in mcg/hr) 2.4 
Hydrocodone 1 
Hydromorphone 4 
Methadone  1-20 mg/day 4 
21-40 mg/day 8 
41-60 mg/day 10 
≥ 61-80 mg/day 12 
Oxycodone 1.5 
Oxymorphone 3 
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Appendix C 
Protection of Human Subjects 
The proposed dissertation study involves a retrospective chart review utilizing data from 
the electronic medical record (EMR) at the University of Cincinnati Medical Center. Because the 
data to be extracted from the EMR were not collected specifically for the proposed 
dissertation study, and no one on the study team will have access to patients' identifying 
information, the study is not considered human subjects research. Expedited Internal Review 
Board (IRB) approval will be obtained. Because this dissertation research involves both the 
University of Cincinnati and Duquesne University, IRB will be obtained from both institutions.  
Initial approval will be sought from Duquesne. Once approved, an IRB/Independent Ethics 
Committee Authorization Agreement form will be submitted to the University of Cincinnati IRB 
for approval along with any other required documentation.   
Following approval by the IRBs at Duquesne University, where the PI is a doctoral 
student, as well as the University of Cincinnati, an honest broker from Biomedical Informatics 
will extract and provide the data in a de-identified, HIPAA compliant, and secure format that 
will not allow linkage to the patient. There are five Epic data based trained analysts on the team 
along with supporting faculty with broad informatics experience to assist in procuring and 
providing the data to the research team in this secure format. The de-identified dataset will be 
stored on a password protected computer, and will only be accessible to members of the research 
team.   
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2.0 INTEGRATIVE REVIEW OF THE LITERATURE 
Manuscript #1 
THE IMPACT OF PATIENT CHARACTERISTICS AND POSTOPERATIVE OPIOID 
EXPOSURE ON PROLONGED POSTOPERATIVE OPIOID USE— 
AN INTEGRATIVE REVIEW 
This chapter is a pre-print version of the article accepted for publication by Pain Management 
Nursing. 
2.1 Abstract 
The United States is experiencing an opioid overdose crisis. Research suggests prolonged 
postoperative opioid use, a common complication following surgery, is associated with opioid 
misuse, which, in turn, is the greatest risk factor of heroin misuse. 
Objectives: To evaluate how postoperative opioid exposure relates to prolonged use and to 
identify factors that predict prolonged postoperative opioid use.  
Design: An integrative review of the literature 
Data Sources: Electronic and hand searching methods were used in PubMed, Embase, Cochrane 
Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, and 
SCOPUS. Search terms included opioid, opiate, postoperative pain, drug administration, 
prescribing pattern, prescription, inappropriate prescribing, self-medication, patient-controlled 
analgesia, opioid-naïve patients, and prolonged opioid use. 
Review/Analysis Methods: Data was synthesized by identifying themes reflecting the results of 
the review. A quality assessment of the articles was also conducted.  
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Results: Fourteen articles were included and two main themes emerged: (1) Surgery places 
opioid naïve patients at risk for prolonged opioid use and (2) Certain patient characteristics may 
be predictive of prolonged postoperative opioid use.  
Conclusions: Prolonged postoperative opioid use is related to factors in addition to prescribing 
practices. Researchers consistently found that patients who are already on opioids, 
benzodiazepines, or addicted to alcohol; who have mental health disorders, depressive 
symptoms, or a self-perceived risk of addiction; and patients with multiple co-morbidities are at 
greater risk of prolonged use; demographics were inconsistent.  
Nursing Implications: Studies are needed to determine the predicting characteristics of 
prolonged postoperative opioid use, the type of surgeries that place patients at most risk, and the 
effect postoperative exposure to opioids has on prolonged use.  This information can be used to 
develop and implement protocols to prevent misuse among high-risk patients. 
2.2 Background 
The opioid crisis in the United States (U.S) has reached epidemic proportions 
(Understanding the Epidemic, 2017). Opioid overdose deaths nearly tripled in the fifteen years 
between 1999 and 2014 (Rudd, Seth, David, & Scholl, 2016). There were 52,404 drug overdose 
deaths in 2015, up from 47,055 in 2014 (Rudd et al., 2016). Of these deaths, 63% (33,091) were 
attributed to opioids, the highest rate ever recorded in a single year (Rudd et al., 2016). 
Provisional data for 2017 indicates 64,070 people will die from unintentional drug overdoses, a 
20% increase from the previous year (Provisional Counts of Drug Overdose Deaths, as of 
8/6/2017, 2017).  
The rate of drug overdose deaths is increasing significantly in both males and females 
and among all adult age groups (Rudd, Akeshire, Zibbell, & Gladden, 2017). Although men 
  30 
continue to misuse opioids more than women, the gap is narrowing ("Prescription Painkiller 
Overdoses," 2013). The Centers for Disease Control and Prevention (CDC) reported a 265% 
increase among men compared to a 400% increase in use among women since 1999; the female 
age groups most affected are women of childbearing age ("Prescription Painkiller Overdoses," 
2013). In addition to the human toll, the economic burden of the opioid epidemic is staggering. 
The CDC’s estimated direct costs to insurers in 2011 for nonmedical use of prescription drugs 
was over $72 billion per year ("Prescription Painkiller Overdoses in the U.S.," 2011). 
In response to this epidemic, there has been an urgent call to action at the national level 
by the U.S. Congress, the CDC, the Department of Health and Human Services (Addressing 
Prescription Drug Abuse in the United States, 2013), the U.S. Department of Justice Drug 
Enforcement Administration (DEA) (2016 National Drug Threat Assessment Summary, 2016), 
and the National Institutes of Health (National Institute on Drug Abuse 2016-2020 Strategic 
Plan, 2016). In fact, the DEA reports that opioids--such as prescription drugs, fentanyl, and 
heroin--are the most significant drug threats facing our country (2016 National Drug Threat 
Assessment Summary, 2016). The strongest predictor of heroin abuse is previous prescription 
opioid misuse, and those who misuse opioids are forty times more likely to become dependent on 
heroin; people often turn to heroin when they are unable to obtain opioid analgesics (Compton, 
Jones, & Baldwin, 2016; Rudd et al., 2016).  
  Research suggests that prolonged postoperative opioid use is a common complication of 
elective surgery (Brummett et al., 2017). Opioids are often overprescribed postoperatively for 
post-surgical pain management, and research indicates that only 28% to 58% of the prescribed 
pills are used by patients after elective procedures (Bates, Laciak, Southwick, & Bishoff, 2011; 
Harris et al., 2014; Harris et al., 2013; Hill, McMahon, Stucke, & Barth, 2017; Kim et al., 2016; 
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Rodgers, Cunningham, Fitzgerald, & Finnerty, 2012). Additionally, wide variation in prescriber 
practices are found not only nationally, but also among surgeons practicing at the same facilities 
(Harris et al., 2014; Hill et al., 2017). The average duration of opioid prescriptions has not 
increased over time; however, the mean morphine equivalents prescribed to opioid naïve 
patients, defined as no opioid prescription in the six months preceding surgery, showed increases 
from 2004 to 2008 and again from 2008 to 2012 in a study examining four common surgical 
procedures: carpal tunnel release, laparoscopic cholecystectomy, inguinal hernia repair, and knee 
arthroscopy (Wunsch, Wijeysundera, Passarella, & Neuman, 2016). 
A review article examining postoperative discharge opioid prescribing reported on three 
studies and concluded that there is evidence of unintended prolonged postoperative opioid use 
(Macintyre, Huxtable, Flint, & Dobbin, 2014). Prescribing practices and predictive patient 
characteristics were not examined in this review.  Current research includes findings regarding 
prolonged postoperative opioid use, characteristics that may contribute to prolonged use, and 
prescribing practices. However, no previous literature reviews were discovered evaluating 
postoperative opioid exposure and the predictive patient characteristics of prolonged opioid use 
after surgery. 
Prescription opioid misuse is a complex and multifaceted problem. Contributors are 
biological, psychological, social, and institutional (Addressing Prescription Drug Abuse in the 
United States, 2013; "Definition of Addiction," 2018). Prolonged opioid use has been described 
as continued use beyond the normal and expected time for healing, with 90 days being the cutoff 
based on multiple definitions and regulations according to the American Society of 
Interventional Pain Physicians Guidelines (Manchikanti et al., 2012). A better understanding of 
patient factors and prescribing practices on prolonged postoperative opioid use may facilitate 
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development of patient focused interventions including screening tools to identify high risk 
patients, pain management protocols and prescribing guidelines, and educational strategies for 
patients, clinicians, and stakeholders. Ultimately, this information may lead to implementation of 
best practice guidelines for acute postoperative pain management.    
2.2.1 Objectives 
The purpose of this integrative review is to evaluate and synthesize current scientific 
literature and evidence on how postoperative opioid exposure is related to prolonged use and to 
identify potential predictive patient characteristics of prolonged postoperative opioid use in the 
U.S. The following questions guided this review:  
(1) Is postoperative exposure to opioids associated with prolonged use? 
(2) Are there specific patient characteristics associated with prolonged postoperative 
opioid use?  
2.3 Methods 
2.3.1 Design 
 An integrative review was conducted according to the methodology of Whittemore and 
Knafl (2005). This type of review includes various types of evidence, both empirical and 
theoretical, and may include randomized controlled trials, qualitative studies, observational 
studies, clinical experts, and gray literature (Whittemore & Knafl, 2005). The components of this 
method are problem identification, literature search, data evaluation, data analysis, and 
presentation (Whittemore & Knafl, 2005, p. 549). The literature search was conducted with the 
aid of health sciences librarians to ensure a thorough and complete search. This review was also 
conducted in accordance with the latest Preferred Reporting Items for Systematic Reviews and 
Meta-analysis (PRISMA) statement (Moher, Liberati, Tetzlaff, Altman, & PrismaGroup, 2009).   
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2.3.2 Data Sources 
 The clinical databases included in the search process were PubMed, Embase, Cochrane 
Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and CINAHL. 
In addition, ClinicalTrials.gov and abstracts from the Annual Meeting of the American Pain 
Society were searched by title for relevancy of unpublished documents for this review; no 
articles were added from either of these two sources. Scopus was also used to check relevant 
article reference lists and citing articles. An ancestry search of the reference section of included 
articles was conducted for completeness. Search strategies were developed by a team of 
researchers based on the clinical question and key terms.  
 Two librarians added additional terms and appropriate subject headings depending on the 
particular database searched (i.e. Medical Subject Headings (MeSH), the National Library of 
Medicine controlled vocabulary; Emtree, the Embase database controlled vocabulary; and 
CINAHL subject headings). The following key search terms were used in strategies specific to 
each database and organization: opioid; opiate; postoperative pain; drug administration; 
prescribing pattern; prescription; inappropriate prescribing; self-medication; patient-controlled 
analgesia; opioid-naïve patients; and prolonged opioid use. See the specific search strategies in 
Table 1.   
Titles and abstracts were screened by the first and second authors to determine if the 
articles met the subject of interest and the inclusion criteria. Articles were included if they were 
published in original, peer-reviewed journals, written in English, from the U.S., and studies of 
adult patients. No date restriction was imposed in any database except CINAHL (January 1, 
2011). Notably, the review by Macintyre (2014) found no articles predating 2012 in their search. 
Articles outside the U.S. were excluded due to different drug formularies and different laws 
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regarding prescribing practices in other countries. Searches in all resources were done through 
June 21, 2017 (See PRISMA Diagram Figure 1). 
After applying the inclusion and exclusion criteria and removing duplicates, 683 titles 
and abstracts were screened. Nineteen articles were initially selected for full text review. Seven 
articles were excluded after the full text review: a study on guideline implementation at a single 
center, a pilot study for an included study, an intervention for preoperative counseling, and four 
that did not meet the inclusion criteria. The ancestry search of the twelve included articles 
produced two more articles, and in total fourteen articles were included in this review. A 
summary of the articles is presented in Table 2.  
 2.3.3 Review Methods 
Data were synthesized by categorizing, summarizing, comparing, and interpreting findings 
across all fourteen articles to identify themes that reflect the focus of the integrative review. Key 
components included: author and publication year, purpose, design, sample/setting, statistical 
analysis, findings, limitations, and recommendations for future research. A matrix of studies 
reviewed is displayed in Table 2. A quality assessment was conducted on articles included in the 
review using a scale adapted from other integrative reviews (Clark, Wilder, & Winstanley, 2014; 
Jinks, Cotton, & Rylance, 2011). The results of the quality assessment are listed in Table 3. Six 
articles did not describe attrition or the process for handling missing data. Three articles did not 
adequately address ethical considerations, specifically whether Institutional Review Board 
approval or consent was obtained.  
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2.4 Results 
2.4.1 Description of Studies  
A total of fourteen articles were included in the final analysis. Five retrospective database 
analyses were included (Brummett et al., 2017; Johnson et al., 2016; Sun, Darnall, Baker, & 
Mackey, 2016; Waljee et al., 2016; Wunsch et al., 2016). The database analyses all consisted of 
commercial insurance claims to examine factors of prolonged opioid use after certain surgeries. 
These studies were limited to patients 18 to 64 years of age with private insurance; Medicare, 
Medicaid, and patients without insurance were not examined. There were three prospective 
observational studies, one of which was a pilot study (Carroll et al., 2012; Harris et al., 2013; 
Kim et al., 2016).  One single site study included both a retrospective chart review and a patient 
survey (Hill et al., 2017). There were two single site retrospective chart reviews (Harris et al., 
2014; Rozet et al., 2014) and two studies based on patient surveys (Bates et al., 2011; Rodgers et 
al., 2012). Lastly, there was one secondary analysis of data (Goesling et al., 2016). The matrix of 
studies is displayed in Table 2.  
  Three of the five database analyses used the Truven Health MarketScan Commercial 
Claims and Encounters data set. This is comprised of 100 U.S. health plans (Johnson et al., 2016; 
Sun et al., 2016; Waljee et al., 2016).  In one study, the records of 77,573 opioid naïve patients 
(defined as no opioid prescription filled in the eleven months prior to surgery) who underwent 
common elective hand surgeries (carpal tunnel release, carpometacarpal arthroplasty/arthrodesis, 
cubital tunnel release, trigger finger release) and common hand surgeries for trauma (closed 
distal radius fracture fixation, flexor tendon repair, metacarpal fracture fixation or phalangeal 
fracture fixation) were examined to determine the risk of prolonged (greater than 90 days) 
postoperative opioid use (Johnson et al., 2016). Another analysis examined the records of 
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296,452 patients who underwent the following common hand surgeries to evaluate opioid use 
due to procedure type and patient factors including preoperative opioid use: carpal tunnel release, 
trigger finger release, cubital tunnel release or thumb carpometacarpal arthroplasty (Waljee et al., 
2016). A third analysis examined 641,941 opioid naïve surgical patients (defined as no opioid 
prescription filled in the twelve months prior to surgery) undergoing eleven common surgeries 
and 18,011,137 opioid naïve non-surgical patients for comparison to see which patients were at 
highest risk for continued opioid use at one year (Sun et al., 2016).   
The data for two of five database analyses were obtained from a managed care company 
affiliated with OptumInsight© through the Clinformatics Data Mart© Database. One examined 
155,297 opioid naïve patients (defined as no opioid prescription filled in the six months prior to 
surgery) undergoing carpal tunnel release, laparoscopic cholecystectomy, inguinal hernia repair, 
and knee arthroscopy in 2004, 2008, and 2012 to analyze the change in prescribing patterns over 
time (Wunsch et al., 2016). The other examined 36,177 patients with private insurance 
undergoing major and minor surgical procedures for comparison (Brummett et al., 2017).  
 There were three prospective observational studies included (Carroll et al., 2012; Harris 
et al., 2014; Harris et al., 2013; Kim et al., 2016). One study enrolled 109 patients having total 
hip replacement, total knee replacement, thoracotomy, mastectomy, or lumpectomy procedures 
in a pilot study (Carroll et al., 2012). Preoperatively, psychological tests were administered and a 
history of substance abuse performed to measure these determinants on prolonged postoperative 
opioid use. Another study examined 212 adults undergoing dermatological surgery to determine 
characteristics associated with opioid prescribing practices and postoperative opioid 
consumption in this surgical population (Harris et al., 2013). The researchers then conducted a 
retrospective chart review of 233 dermatological surgical patients along with a survey emailed to 
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members of the American Society for Dermatological Surgery to increase understanding of 
prescribing practices in this population (Harris et al., 2014). The third prospective study 
examined 1,419 patients age 18 to 93 after outpatient procedures involving the hand, wrist, 
forearm, or shoulder (Kim et al., 2016). Data was collected prospectively and a telephone 
interview determined the number of opioid pills used after surgery.   
 Three studies used patient surveys to obtain data (Bates et al., 2011; Hill et al., 2017; 
Rodgers et al., 2012). In one study, a sample of urology surgery patients was used to examine 
prescribing practices, opioid consumption, and disposal of surplus medication (Bates et al., 
2011). Another examined 250 patients undergoing elective outpatient upper extremity surgeries 
using a post-surgical phone interview to assess pain control and consumption of opioids 
postoperatively (Rodgers et al., 2012). In the third study, researchers contacted opioid naïve 
patients (defined by the researchers as no opioid use 30 days prior to surgery) undergoing five 
common general surgery procedures (partial mastectomy, partial mastectomy with sentinel 
lymph node biopsy, laparoscopic cholecystectomy, laparoscopic inguinal hernia repair, and open 
inguinal hernia repair) to determine how many opioid pills were taken postoperatively (Hill et 
al., 2017). Lastly, a retrospective chart review of 145 veterans undergoing knee arthroscopies to 
identify risk factors for chronic postoperative pain, especially post-traumatic stress disorder 
(PTSD) was completed (Rozet et al., 2014). This study reviewed medical and pharmacy records 
of 18 to 50-year-old patients at a single site.   
2.4.2 Synthesis of Studies  
The purpose of this review was to synthesize current scientific literature and evidence on 
how postoperative opioid exposure is related to prolonged use and to identify potential predictive 
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characteristics of prolonged postoperative opioid use. Careful analysis and synthesis of these 
articles resulted in the emergence of two major themes.  
2.4.2.a. Surgery places patients at risk for prolonged opioid use. 
Five studies suggest that surgery places opioid naïve patients at risk for prolonged 
postoperative opioid use (Brummett et al., 2017; Carroll et al., 2012; Goesling et al., 2016; 
Johnson et al., 2016; Sun et al., 2016). Prolonged use was defined as (1) filling an opioid 
prescription 90 to 180 days after surgery (Brummett et al., 2017; Johnson et al., 2016), (2) filling 
either more than 120 days’ supply of opioids or 10 or more refills 90 to 365 days after surgery 
(Sun et al., 2016), or (3) filling a prescription more than180 days after surgery (Goesling et al., 
2016). In a study of patients undergoing major surgeries such as mastectomies, thoracotomies, 
and total joint replacements, median time to opioid cessation post-surgery was calculated: 6% of 
opioid naïve patients continued to use opioids more than 150 days after these procedures (Carroll 
et al., 2012). Compared with the 0.136% baseline rate of opioid use measured in nonsurgical 
reference groups, rates of opioid use more than 90 days after surgery were significantly greater 
for all surgical procedures other than cesarean sections (Sun et al., 2016). In this study, patients 
undergoing total knee replacements (TKA) had the highest rates of chronic opioid use (1.41%) 
followed by two common surgeries: simple mastectomies and total hip replacements (THA) 
(0.6%). Similarly, 6.5% of patients undergoing major surgeries such as colectomies, bariatric 
surgeries, and hysterectomies and 5.9% of patients undergoing minor surgical procedures such as 
thyroidectomies, parathyroidectomies, and laparoscopic cholecystectomies were still taking 
opioids more than 90 days after their surgery (Brummett et al., 2017). There was no significant 
difference between the two surgical groups in regard to prolonged postoperative opioid use. 
There was a significant difference, however, when compared to the 0.4% rate of new persistent 
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opioid use in the nonsurgical control group (Brummett et al., 2017). Patients undergoing TKA 
and THA were surveyed at one, three, and six months post-surgery. At six months, 8.2% of TKA 
and 4.3% of THA patients were still using opioids (Goesling et al., 2016). Lastly, in patients 
undergoing common elective hand surgeries, 13% of opioid naïve patients continue to fill 
prescriptions 90 days after their surgical procedure (Johnson et al., 2016).  
Among these studies, evidence varies on how the type of surgery influences prolonged 
postoperative opioid use. In a study of 11 procedures, research suggests total joint replacements, 
mastectomies, and open and laparoscopic cholecystectomies and hernia repairs are more likely to 
lead to prolonged postoperative opioid use than open and laparoscopic appendectomies, 
functional endoscopic sinus surgeries, cataract surgeries, transurethral prostate resections, and 
simple mastectomies (Sun et al., 2016). However, other findings suggest no significant 
difference in prolonged opioid use between patients undergoing major and minor surgeries 
(Brummett et al., 2017). In addition, no association was found between change in joint pain over 
time and prolonged opioid use in patients undergoing joint replacement surgeries (Goesling et 
al., 2016). The percentage of opioid naïve patients continuing to use opioids more than 90 days 
across diverse procedures after their procedure indicates that this prolonged use should be 
viewed as a surgical complication (Brummett et al., 2017).   
Lastly, many studies suggest that postoperative opioid prescribing practices may 
contribute to prolonged use.  Multiple studies indicate that opioids are overprescribed after 
surgery, leading researchers to conclude that this could potentially contribute to misuse and 
diversion (Bates et al., 2011; Harris et al., 2014; Harris et al., 2013; Rodgers et al., 2012). Two 
studies show wide variation in prescribing practices, even for the same surgery; whether this is 
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due to varying patient needs or other provider factors is not clear (Harris et al., 2013; Hill et al., 
2017). 
2.4.2.b Certain patient characteristics may be predictive of prolonged postoperative 
opioid use. 
 Patient characteristics may be predictive of prolonged postoperative opioid use, but these 
are inconsistently reported across studies. Demographics such as gender, age, race, ethnicity, and 
socioeconomic status were particularly inconsistent as predictors. For instance, in one analysis, 
patient demographics predicting prolonged postoperative opioid use were significant for those 
less than 65 years of age, female gender, household income under $60,000 per year, and private 
insurance (Johnson et al., 2016). Conversely, in another database analysis, men and those over 
50 years of age had higher rates of prolonged use (Sun et al., 2016). Yet another study found no 
difference in opioid use six months after surgery by age, gender, ethnicity, or type of surgery 
(Goesling et al., 2016). Rates also varied by geographic location. Statistically significant higher 
rates of prolonged postoperative opioid use were found in the U.S. Census Bureau West South 
Central (7.02%) and East South Central (7.85%) regions compared to the Middle Atlantic 
Region (3.78%) (Brummett et al., 2017). 
Researchers consistently found that patients who are currently using opioids, 
benzodiazepines, or addicted to alcohol were at increased risk of prolonged postoperative 
use (Brummett et al., 2017; Goesling et al., 2016; Johnson et al., 2016; Rozet et al., 2014; 
Sun et al., 2016; Waljee et al., 2016). In fact, mental health disorders such as anxiety and 
depression, tobacco and alcohol abuse, multiple co-morbidities, and pre-existing pain conditions 
were independent predictors of prolonged postoperative opioid use across all surgical procedures 
(Brummett et al., 2017; Johnson et al., 2016). Preoperative opioid prescriptions, depressive 
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symptoms, and self-perceived risk of addiction were better predictors of prolonged use than 
the reported postoperative intensity and duration of pain (Carroll et al., 2012). One study 
found that a preoperative opioid prescription greater than 60 morphine milligram equivalents 
per day was associated with prolonged use after surgery (Goesling et al., 2016). Additionally, 
patients already on opioids preoperatively were often overprescribed opioids postoperatively 
(Waljee et al., 2016). Lastly, PTSD and preoperative opioid use were factors leading to chronic 
postoperative opioid use in young veterans having minor elective surgeries (Rozet et al., 2014). 
2.5 Discussion 
Studies included in this integrative review indicate that 4% to 13% of opioid naïve 
patients are taking opioid pain relievers three months or more after their procedure, suggesting 
that prolonged postoperative opioid use occurs frequently after elective surgery in this population 
(Brummett et al., 2017; Carroll et al., 2012; Goesling et al., 2016; Johnson et al., 2016; Sun et al., 
2016).  It is unclear which surgeries, if any, carry the highest risks for patients. Moreover, 
research findings suggest that prolonged opioid use after surgery is related to factors other than 
the type and duration of surgical pain (Carroll et al. 2012).  
Current evidence suggests that prolonged postoperative opioid use is related to exposure 
through prescriptions and to patient characteristics. Across multiple studies, patients who were 
already using opioids, benzodiazepines, antidepressants, anxiolytics, tobacco, or abusing alcohol 
were at higher risk for prolonged postoperative opioid use (Brummett et al., 2017; Goesling et 
al., 2016; Johnson et al., 2016; Rozet et al., 2014; Sun et al., 2016; Waljee et al., 2016). 
Mental health disorders, depressive symptoms, a self-perceived risk of addiction, and multiple 
co-morbidities also independently predicted prolonged use (Brummett et al., 2017; Carroll et al., 
2012; Johnson et al., 2016). The contribution of patient demographics is unclear. Further 
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evidence is needed to ascertain the contribution of patient characteristics to prolonged 
postoperative opioid use. 
Large prospective studies are needed to determine which surgeries place patients at an 
increased risk for prolonged opioid use, how prescribing practices affect prolonged use, and 
which patient factors contribute to prolonged use. Notably, there are inconsistencies among 
researchers as to the definitions of “prolonged opioid use” and “opioid naïve.” Standard 
definitions would provide consistency and allow comparison of results across studies. Ultimately 
these studies will lead to evidenced based prescribing practice guidelines and improved 
perioperative pain management.  
2.6 Implications for Nursing 
Based on current evidence, two million patients undergoing elective surgeries each year 
will use opioid analgesics more than 90 days after their procedure (Brummett et al., 2017). It is 
imperative that nurses and other clinicians appropriately manage surgical patients preoperatively, 
intraoperatively, at discharge, and throughout the recovery period in order to prevent prolonged 
use of these medications. Nurses need to screen opioid naïve patients preoperatively using the 
factors we have uncovered placing them at higher risk for prolonged postoperative opioids use: 
patients currently taking, benzodiazepines, antidepressants, anxiolytics, tobacco, or abusing 
alcohol, as well as those patients with mental health disorders, depressive symptoms, a self-
perceived risk of addiction, and multiple co-morbidities. Nurses also need to educate patients on 
postoperative pain control expectations, expected time to recovery, and follow the patients 
closely after discharge. The wide variations in prescriber practices, the large percentage of 
unused opioids, and the increase in potency of opioids prescribed highlights the need for 
postoperative prescribing guidelines (Bates et al., 2011; Harris et al., 2014; Hill et al., 2017; Kim 
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et al., 2016; Rodgers et al., 2012; Wunsch et al., 2016). Nurses can counsel patients on 
appropriate use and disposal of opioids, non-narcotic pain relievers, and non-traditional pain 
control techniques. Additionally, acute pain should be managed through multi-modal pain relief 
techniques including perioperative anesthetics that are opioid sparing.  
Both qualitative and quantitative studies are needed for a better understanding of factors 
related to prolonged postoperative opioid use, the type of surgeries that place patients at most 
risk, and the effect postoperative exposure to opioids has on prolonged use. This will facilitate 
development of patient focused interventions including screening tools to identify high risk 
patients, pain management protocols and prescribing guidelines, and educational strategies for 
patients, clinicians, and stakeholders. Nurses are poised to develop and refine evidenced based 
tools that will inform best practices for acute postoperative pain management. 
2.7 Limitations 
 There are several limitations to this integrative review. First, there is a relatively small 
body of research related to this topic and some of the studies were by the same author group, 
indicating a need to replicate the research in other samples. There are also a variety of 
methodological limitations to the studies analyzed. There are no randomized controlled trials and 
there were no qualitative analyses. Some studies relied on self-reports from patients and may 
therefore be biased by inaccurate recall or an unwillingness to be forthcoming about the 
medications used, especially if they are supplementing with illicit drugs. Several studies relied 
on insurance database information that may be incomplete or inaccurate. Additionally, the 
database reviews may not be reflective of the general population as those with Medicare and 
Medicaid, and the uninsured were not represented. Some of the databases were geographically 
limited.  
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In addition to methodological limitations, opioid naïve was defined differently by 
different authors. Furthermore, alternative methods for pain control, such as multi-modal 
analgesia techniques that augment the efficaciousness of opioids, were not discussed. The 
possibility of illicit drug use in patients was not investigated in these studies and should be 
included if possible in future research. 
2.8 Conclusions 
This integrative review includes a synthesis of the association between postoperative 
exposure to opioids and specific patient characteristics associated with prolonged postoperative 
opioid use. Findings from this review identify gaps in our current knowledge and support the 
need for future research. This review indicates that prolonged postoperative opioid use is 
common after surgical procedures and is related to postoperative opioid exposure and patient 
factors rather than the duration and intensity of post-surgical pain. Characteristics putting 
patients at higher risk were mental health disorders, multiple co-morbid conditions, and the 
preoperative use of opioids, benzodiazepines, antidepressants, anxiolytics, as well as tobacco or 
alcohol abuse. The contribution of patient demographics is unclear as is the type of surgery, 
whether major or minor. Further research describing the effects of postoperative opioid exposure 
on prolonged opioid use, postoperative opioid prescribing practices, and the identification of 
potential predictive characteristics of prolonged postoperative opioid use. It is crucial for 
advanced practice clinicians, surgeons, nurses, and other healthcare professionals to better 
understand which patient populations are at an increased risk and preemptively prevent misuse 
from occurring.   
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Table 1   
Electronic Database Search Strategies 
Electronic Database Search Strategy 
 
CINAHL 
 
(MH "Postoperative Pain" OR MH "Patient-Controlled Analgesia" OR TI 
post* N4 pain* OR AB post* N4 pain* OR TI patient-controlled N4 
analgesi* OR AB patient-controlled N4 analgesi*) AND (MH "Prescribing 
Patterns" OR MH "Inappropriate Prescribing" OR MH "Prescriptions, 
Drug" OR MH "Self Administration+" OR MH "Self Medication" OR TI 
prescrib* N4 practice OR AB prescrib* N4 practice) Limits: 2011/01/01 to 
2017/06/21; United States 
 
Cochrane Database of Systematic 
Reviews 
((opioid or opiate or opioid-naive) OR ("substance use disorder" or "drug 
abuse")) AND (postsurgical or postoperative) AND ("prescribing practice" 
or prescribe or prescription) 
 
Cochrane Central Register of 
Controlled Trials 
((opioid or opiate or opioid-naive) OR ("substance use disorder" or "drug 
abuse")) AND (postsurgical or postoperative) AND ("prescribing practice" 
or prescribe or prescription) 
 
EMBASE (‘Opiate’/mj OR ‘prescription’/mj OR ‘prescription opioids’:ab,ti OR 
‘inappropriate prescribing’/mj OR ‘potentially inappropriate 
medication’/mj OR ‘drug abuse’/mj OR ‘opioid-naïve patients’:ab,ti) AND 
(‘surgical patient’/mj OR ‘postoperative pain’/mj OR ‘postoperative 
complication’/mj OR ‘postoperative care’/mj OR ‘prolonged opioid 
use’:ab,ti) AND ([young adult]/lim OR [adult]/lim OR [middle aged]/lim 
OR [aged]/lim OR [very elderly]/lim) AND [english]/lim 
 
PubMed (("Practice Patterns, Physicians'”[Mesh] OR prescribing pattern*[tiab] OR 
"Drug Administration Schedule"[Mesh] OR “Analgesics, Opioid”[Mesh] 
OR “opioid use”[tiab] OR “opioid-naive patients”[tiab]) AND (“surgery 
procedures”[tiab] OR surgery[tiab]) AND ("Pain, Postoperative"[Mesh] 
OR “postoperative period”[tiab] OR “postoperative pain”[tiab])) AND 
"united states"  
 
ClinicalTrials.gov postoperative opioid prescription Limits: Adults; United States 
 
Annual Meeting of the American 
Pain Society 
postoperative opioid 
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Table 2   
Summary of Included Articles 
 
Authors (year) Objective Method Sample Results 
Bates et al. (2011) To determine if urologists are 
overprescribing opioids after 
surgery 
 
Patient surveys 275 patients undergoing 
urology surgery 
Over 40% of prescribed opioids 
were not used and 67% of patients 
had leftover pain medication. 
Opioids are overprescribed after 
surgery. 
 
Brummet et al. (2017) To determine incidence of 
prolonged postoperative opioid 
use in opioid naïve patients 
after major and minor surgeries 
Retrospective 
database analysis 
36,177 patients from a 
managed care insurance 
affiliated with 
OptumInsight from 
Clinformatics Data Mart 
who underwent 13 
common surgical 
procedures 
 
5.9% to 6.5% of opioid naïve 
patients continued to use opioids > 
90 days post-surgery whether the 
procedure was major or minor, 
suggesting factors other than pain 
contribute to long term use. 
Carroll et al. (2012) To determine if psychological 
distress and substance abuse are 
predictors of prolonged 
postoperative opioid use (pilot 
study) 
Prospective, 
longitudinal 
observational study  
109 patients undergoing 
mastectomy, 
lumpectomy, 
thoracotomy, total knee 
replacement, or total hip 
replacement 
 
6% of patients continued on opioids 
> 150 days post-surgery.  Predictors 
were preoperative opioid use, 
depression, and self-reported 
perceived risk of addiction. 
Goesling et al. (2016) To determine patient risk 
factors for chronic post-op 
opioid use, the effect of pain 
scores preoperatively and at 6 
months after TKA and THA on 
opioid use, and to explore the 
natural course of opioid use in 
these surgical patients 
Secondary analysis 
of data from a 
prospective outcome 
study that used 
telephone and mail 
surveys 
574 patients who had 
TKA or THA  
8.2 % of opioid naïve TKA and 
4.3% of opioid naïve THA patients 
continued on opioids 180 days-post-
surgery. Pre-op opioid dose > 
60MME was independently 
associated with chronic opioid use, 
and there was no association found 
between change in joint pain over 
time and chronic opioid use. 
 
Harris et al. (2013) To understand (1) postoperative 
opioid prescribing by 
dermatologists, (2) the amount 
of postoperative pain 
Prospective 
observational study 
utilizing telephone 
follow up 
212 patients undergoing 
single skin excision 
surgical procedures 
34% of patients received a 
postoperative opioid prescription. 
86% of patients who filled a 
prescription had leftover pills and 
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medications actually used, and 
(3) patient and surgical factors 
associated with amount used 
53% planned to store them for 
future use. Female, younger age, 
and surgery type were predictors of 
increased opioid use 
postoperatively, but the overall fit of 
the model was limited. Surgery with 
graft closures was the only surgical 
characteristic indicative of increased 
pain. Opioids are overprescribed 
after surgery. 
 
Harris et al. 
(2014) 
To understand postoperative 
opioid prescribing practices  
 
Retrospective chart 
review and email 
survey to 
dermatologists 
 
233 patients who had 
undergone single skin 
excision surgical 
procedures and an email 
survey of 556 members 
of the American Society 
for Dermatological 
Surgery 
 
There is wide variation in 
prescribing practices among 
dermatologists nationally and within 
the same institution. Opioids are 
overprescribed after surgery. 
Hill et al. (2017) To (1) examine opioid 
prescribing practices after 
general surgery and (2) 
determine the number of pills 
that should be prescribed 
EMR chart review 
& patient survey 
642 patients undergoing 
partial mastectomy, 
partial mastectomy with 
sentinel lymph node 
biopsy, laparoscopic 
cholecystectomy, 
laparoscopic inguinal 
hernia repair, and open 
inguinal hernia repair 
 
72% of prescribed opioids were not 
used and there was a wide variety of 
prescribing practices among 
prescribers at same facility. Opioids 
are overprescribed after surgery. 
 
Johnson et al. (2016) To evaluate opioid use in 
opioid naïve patients after 
common hand surgeries 
Retrospective 
insurance database 
analysis 
59,735 patients from the 
Thomson Reuters 
Truven MarketScan 
Commercial Claims 
Database 
 
13% of opioid naïve patients 
continued to fill opioid prescriptions 
greater than 90 days post-surgery. 
Kim et al. (2016)  To evaluate opioid usage after 
outpatient upper extremity 
surgery 
Prospective 
observational study 
1,416 patients who had 
outpatient upper 
extremity surgery 
66% of prescribed opioids were not 
used; opioids are overprescribed 
after surgery which could lead to 
misuse and diversion. Procedure 
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type and location, patient age, and 
type of insurance determined 
increased postoperative opioid 
consumption. 
 
Rodgers et al. (2012) To determine the amount of 
unused opioids after outpatient 
upper extremity surgery  
 
Patient survey 250 outpatients who had 
upper extremity surgery 
77% of patients took less than half 
of their prescribed opioids. The 
number of opioids used differed by 
insurance type. 
 
Rozet et al. (2014) To determine patient risk 
factors for chronic 
postoperative pain 
Single center 
retrospective study 
145 young veterans (age 
18-50) having minor 
elective surgeries 
Patients with PTSD are at higher 
risk for prolonged post-op opioid 
use.  Preoperative opioid use is the 
primary risk factor for chronic pain 
post-surgery. 
 
Sun et al. (2016) To compare opioid naïve 
patients undergoing eleven 
types of surgery with 
nonsurgical patients to examine 
the relative risk of prolonged 
opioid use  
 
Retrospective 
insurance database 
analysis  
641,941 opioid naïve 
surgical patients and 
18,011,137 opioid naïve 
non-surgical patients 
from the Thomson 
Reuters Truven 
MarketScan Commercial 
Claims Database 
Increased rate of chronic opioid use 
in patients undergoing TKA, THA, 
open and laparoscopic 
cholecystectomy, open and 
laparoscopic appendectomy, simple 
mastectomy, FESS, and cesarean 
delivery. Patient factors contributing 
to prolonged opioid use were 
preoperative use of 
benzodiazepines, antidepressants, 
and history of drug abuse. 
 
Waljee et al. (2016) To evaluate opioid use after 
four common hand surgery 
procedures    
Retrospective 
insurance database 
analysis 
296,452 patients from 
the Thomson Reuters 
Truven MarketScan 
Commercial Claims 
Database 
4.5% of patients received an opioid 
refill after minor hand surgery. 
Factors associated with refills were 
age, type of insurance, type of 
surgery, and preoperative opioid 
use.  
  
Wunsch et al. (2016) To examine trends in 
prescribing practices over time 
for opioid naïve patients 
undergoing four low risk 
surgeries. Time points 
Retrospective 
insurance database 
analysis 
155,297 opioid naïve 
patients from the 
Clinformatics Data Mart 
Database undergoing 
The proportions of patients filling 
prescriptions for any opioid 
increased over time and the mean 
morphine equivalents prescribed 
increased over time.   
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examined were 2004, 2008, 
2012 
low risk surgical 
procedures  
     
 
Note: TKA = total knee arthroplasty; THA = total hip arthroplasty; MME = morphine milligram equivalent dose; EMR = electronic 
medical record; PTSD = post-traumatic stress disorder; FESS = functional endoscopic sinus surgery  
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Table 3  
Quality Assessment of Included Articles 
 
Note. N/A, not applicable.  Criteria adapted from Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review 
of community opioid overdose prevention and naloxone distribution programs. J Addict Med, 8(3), 153-163 and  Jinks, A., 
Cotton, A., & Rylance, R. (2011). Obesity interventions for people with a learning disability: an integrative literature review. J 
Adv Nurs, 67(3), 460-471.
 
 
 
 
Research 
questions/ 
objectives/ 
hypotheses 
clear and 
appropriate 
Clear overview of 
intervention with 
use of appropriate 
outcome measures 
 
Sample 
size given 
Attrition 
rate/missing 
data discussed 
Data analysis 
adequately 
described and 
rigorous 
Outcomes 
clearly 
described 
Ethical issues 
are suitably 
addressed 
Total 
Score 
Bates et al. (2011) 1 1 1 1 1 1 1 7 
Brummet et al. (2017) 1 1 1 1 1 1 1 7 
Carroll et al. (2012) 1 1 1 0 1 1 0 5 
Goesling et al. (2016) 1 1 1 1 1 1 1 7 
Harris et al. (2013) 1 1 1 0 1 1 1 6 
Harris et al. (2014) 1 1 1 1 1 1 1 7 
Hill et al. (2017) 1 1 1 1 1 1 1 7 
Johnson et al. (2016) 1 1 1 1 1 1 1 7 
Kim et al. (2016) 1 1 1 0 1 1 1 6 
Rodgers et al. (2012) 1 1 1 1 1 1 0 6 
Rozet et al. (2014) 1 1 1 0 1 1 1 6 
Sun et al. (2016) 1 1 1 0 1 1 N/A 5 
Waljee et al. (2015) 1 1 1 1 1 1 0 6 
Wunsch et al. (2016) 1 1 1 0 1 1 1 6 
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